AlainCo Tech-watcher, admin
  • Male
  • from Villejuif
  • Member since Feb 9th 2014
  • Last Activity:

Posts by AlainCo

    https://bmcinfectdis.biomedcen…0.1186/s12879-021-06348-5

    Background

    Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) has changed our lives. The scientific community has been investigating re-purposed treatments to prevent disease progression in coronavirus disease (COVID-19) patients.

    Objective

    To determine whether ivermectin treatment can prevent hospitalization in individuals with early COVID-19.

    Design, setting and participants: A randomized, double-blind, placebo-controlled study was conducted in non-hospitalized individuals with COVID-19 in Corrientes, Argentina. Patients with SARS-CoV-2 positive nasal swabs were contacted within 48 h by telephone to invite them to participate. The trial randomized 501 patients between August 19th 2020 and February 22nd 2021.

    Intervention

    Patients were randomized to ivermectin (N = 250) or placebo (N = 251) arms in a staggered dose, according to the patient’s weight, for 2 days.

    Main outcomes and measures

    The efficacy of ivermectin to prevent hospitalizations was evaluated as primary outcome. We evaluated secondary outcomes in relationship to safety and other efficacy end points.

    Results

    The mean age was 42 years (SD ± 15.5) and the median time since symptom onset to the inclusion was 4 days [interquartile range 3–6]. The primary outcome of hospitalization was met in 14/250 (5.6%) individuals in ivermectin group and 21/251 (8.4%) in placebo group (odds ratio 0.65; 95% confidence interval, 0.32–1.31; p = 0.227). Time to hospitalization was not statistically different between groups. The mean time from study enrollment to invasive mechanical ventilatory support (MVS) was 5.25 days (SD ± 1.71) in ivermectin group and 10 days (SD ± 2) in placebo group, (p = 0.019). There were no statistically significant differences in the other secondary outcomes including polymerase chain reaction test negativity and safety outcomes.

    Limitations

    Low percentage of hospitalization events, dose of ivermectin and not including only high-risk population.

    Conclusion

    Ivermectin had no significant effect on preventing hospitalization of patients with COVID-19. Patients who received ivermectin required invasive MVS earlier in their treatment. No significant differences were observed in any of the other secondary outcomes.

    ^^ :D ;( So true

    If you cannot lead, just connect leaders, give them informations, find the one who share the same desire, and feed them with data, with "date".

    In case you missed it, about the Covid Profiteers

    https://252f2edd-1c8b-49f5-9bb…24d82b271a75e441cd06c.pdf

    12 people manipulate masses

    $36million industry, for 22 organizations. 266 employees

    $1.5million of federal loans through PPP (USA)

    total social media value is about $1.1 billion

    Using affiliate marketing , paying for example $14Mn to partners.


    Note that I expect the same guy oppose LENR, as it oppose their business.

    ;) (not fun in fact)

    "No deaths have been associated with this side effect." says CDC...(not sure if trustful in the end...). At a rate of 12 per million but no deaths this seems to be a more rare acceptable severe side effect vs others, as we know...

    Just about letality, I've heard letality for kids was low, 100 per million 8|

    and don't forget that it is only a question of time, everybody will face Sars-Cov-2, everybody... monre contagious than flu, not far from Measle or winter cold...


    about kids, about 1000/million experience complex inflamation reaction on some organs...


    When you decide about risk, compare to the alternative, not to zero .


    By the way, in Indonesia the epidemic is getting crazy , because of Delta variant from india... kids start to get really impacted... my dear is not the kind to be easily afraid, but it seems now she is.

    I'm the kind who thing they exaggerate on variants, but here , it seems serious.


    By the way mRNA and AZ vaccins works perfectly after 2 doses...

    Metallurgical characterization of Pd electrodes employed in calorimetric experiments under electrochemical deuterium loading


    https://www.academia.edu/30154…hemical_deuterium_loading

    An old paper that may helps experimenters... Involving teams at ENEA, SRI and Navy NRL


    Quote

    A systematic approach has been followed in the production and characterization of Pd foils to be used in excess heat production experiments (1)( 2) (3). Starting with a metal foil as supplied, palladium samples have been fabricated and characterized in a step by step process, and then subjected to electrolysis deuterium loading. The characterized metallurgical properties include the main grain size, the grain boundary, the material Vickers hardness, and the crystal grain orientation. Electrochemical properties that are recorded include the D/Pd loading ratio and the D/Pd low current loading ratio. A suitable correlation parameter has been defined and correlations have been found between excess heat production and individual properties; i.e. the mean grain size, grain boundary, material hardness, crystal grain orientation, deuterium loading and low-current deuterium loading level.

    Relayed by Carl Page.

    Not sure we did not already post this


    NHK LENR Documentary Feb 2021


    External Content www.youtube.com
    Content embedded from external sources will not be displayed without your consent.
    Through the activation of external content, you agree that personal data may be transferred to third party platforms. We have provided more information on this in our privacy policy.


    If someone can analyse it's content...

    About Edmund Storms pressed powder, did someone ask for the size of the powder ? The process of production ?


    Claytor describes a process, precipitation, maybe was it the same?

    Quote

    The palladium powder was obtained from Englehard and formed by precipitation from an aqueous solution
    of Pd(NH3)4Cl2
    using reagent quality chemicals. This process results in an powder composed of small (0.3 to 0.5µm) spheres that form chains or agglomerates up to 30 µm in dia.

    T.N.Claytor, D.G.Tuggle, and H.O.Menlove [1991, Los Alamos]


    Tritium from pressed palladium powder

    Great finding.

    I've found a better print on lenr-canr.org

    https://www.lenr-canr.org/acrobat/ClaytorTNtritiumgen.pdf


    Quote

    The palladium powder was obtained from Englehard and formed by precipitation from an aqueous solution
    of Pd(NH3)4Cl2 using reagent quality chemicals. This process results in an powder composed of small (0.3 to 0.5 µm) spheres that form chains or agglomerates up to 30 µm in dia. The raw material was said to be virgin sponge obtained from a South African mine. The major impurities in the palladium are oxygen (980 ppm) Chlorine (80 ppm), Nitrogen (65 ppm) and Carbon (47 ppm), all other major impurities are (each) under 35 ppm by weight. A total of 512.7 g of palladium powder has been used in the experiments described in this paper, of that amount, 87.3 g was used in various control experiments to test for tritium contamination. Palladium powder was not reused in experiments once it had been removed from a cell. A total of 43.2 g of palladium foil from Johnson and Matthey was used in the foil cells; 0.44 g of this foil was checked for tritium contamination by dissolution7 . The 220 micron thick foils were laser cut and then annealed at 850 C for 2 hours at 10-6 torr. After the dehydride, the foil was reannealed at 850 C and reused. These foils have been hydrided, dehydrided and annealed seven times and show
    neither a monotonic decrease or increase in tritium production.

    ...

    In some cells, Sb doped silicon wafers (0.01 ohm-cm in resistivity by 0.5 mm thick disks, 3.07 cm dia.)
    obtained from Monsanto were used. Between the silicon wafers would be placed the 220 µm thick palladium foil. Because of surface roughness, the plates would only touch over a small fraction of their surface area. Four types of cells have been made: those with palladium powder and silicon powder, those with palladium foil and silicon powder, those with palladium foil and silicon wafers and one with palladium foil and silicon powder. A typical cell, made with powders, might contain 12 to 21 grams of palladium in eight layers (one to two grams per layer) and 6 to 8 grams of silicon distributed between seven layers. Silicon layers are typically 0.76 to 2.15 mm thick by 3.17 cm in dia. while the palladium layers vary from 1.16 to 0.48 mm thick by 3.05 cm in dia. for different type cells. The palladium powder was pressed (11.2 MPa, 2000 psi) into disk form and then oxidized, in air, at 350 C for 2 hours (weight gain of 0.37%). Layers of alternating palladium disks and silicon powder were then pressed into a ceramic form at a pressure of 11.2 MPa resulting in densities of 26% and 68% of theoretical density for the palladium and silicon respectively.

    Not exactly as Edmund Storms explains, but not far...


    What is the initial de-annealing at 850°C/10^-6Torr? looks like the 900-1000°C in vacuum indicated by Edmund Storms.

    Oxidation in air at 350°C is not far from the baking above 400°C indicated by Edmund Storms

    Density is 26% instead of 50%...


    The structure is different, as it was electrolysis, and with various configuration of "sandwich" including silicon... I don't understand the details on that point...

    Neither I understand the hydrogenation phase...

    They said future conferences will be "hybrid," meaning some people will attend in person, while others attend via Zoom.


    I expect Zoom will improve. It is awkward in some ways. It is okay for casual use, but I think it could be improved for large meetings....

    I've seen same problems at RNBE (Cisco Webex is maybe better quality, but less intuitive).

    Hybrid for me is the future.


    Making a good show is a job, if you present something remotely, you must have the good hardware, software, tuning... It is not the usual job of a scientist, even if some at least know the basics of TedX video by instinct and experience.

    It should become a job, to build and tune the "home studio", like what youtubers have... I tortured for a few months my colleagues with a Bluetooth helmet , until I finally found a professional DECT helmet...

    For me a special kind of hybrid could be a hierarchically hybrid... people meeting not far from home, in a well-designed studio, conference room, with all needed, from good camera, good mikes, good broadband network, ready to use computers, careful and competent staff, good coffee and why not individual helmets or remote translators. It could be proposed by bars, restaurants, and it is not so expensive... it requires experience to buy the good hardware/software, but all can be affordable...

    Some presenter and participant still at home, with a dedicated staff bringing them all needed, including carefulness and competence.

    Of course, it would be better to be in the same room in the same city, but it's exhausting, expensive, and sometime impossible. ICCF could be organized with "remote-office" if few cities? Organized by local LENR societies...


    Remote meetings could be more casual, more frequent, for people who know well each other (I practice it at work, existing teams work well remotely, new teal, it is harder). Let's say, that RNBE attendant met every 3 month, for few presentations and long chat... But meeting, if only to share a beer and chat unproductively, is important for efficient teams.


    One fantastic things with remote is the ability to include more people, people with no budgets, with logistics limitations.


    Another is asynchronicity. People who did not attend ICCF23, would be able to ask questions to a presenter, later, but with more details... or ask peers their opinion...


    World is changing...


    Thanks to the past and future organizers.

    Le LEC cité par Alan est une expérience simple en apparence, qui, si elle est reproduite, peut créer une prise de conscience.


    Les Projets Hermes et CleanHME sur fonds Européens sont à suivre.


    Les réplications de Mizuno n'avancent pas vite, ou pas publiquement... Où un détail a été raté...


    La conférence ICCF23 va peut être, être l'occasion d'une sortie intéressante...

    TL/DR: They find excess heat of 120 J in an hour and transmutations on the laser targetted surfaces. IMHO they tried to replicate part of Holmlid's results by simply shooting lasers to Pd hydrides (in reality thy quote many previous laser targetting Pd hydrides papers, and not Holmlid at all). The excess heat calculations are somewhat broad and with plenty of assumptions, the transmutation results might be more interesting in this regard as proof of something exotic going on.

    Note it is Pd with 1H , not as usual 2D . Great.

    About new elements identified, as it is gas loading, situation is much cleaner than with wet cells

    Curbina maybe we can start a thread somewhere else ?